Literature DB >> 6144759

Kinetics and distribution of the beta-adrenergic agonist salbutamol in rat brain.

S Caccia, M H Fong.   

Abstract

the kinetics of the beta-adrenergic agonist salbutamol and its distribution in the central nervous system were examined in rats by high-performance liquid chromatography with electrochemical detection. After 10 mg kg-1 i.v. salbutamol, the decline in drug plasma concentrations was biphasic and salbutamol was cleared very rapidly with a beta-half-life of about 37 min. Salbutamol rapidly penetrated the 'blood-brain barrier' and reached brain concentrations amounting to about 5% of the plasma concentrations. In structures outside the blood-brain barrier (pineal and pituitary glands) the drug achieved concentrations more than 100 times those in whole brain. The results support the hypothesis that stimulation of central beta-adrenergic sites is responsible for salbutamol's pharmacological and biochemical effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144759     DOI: 10.1111/j.2042-7158.1984.tb06941.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

Review 1.  Athletes and doping: effects of drugs on the respiratory system.

Authors:  P N Dekhuijzen; H A Machiels; L M Heunks; H F van der Heijden; R H van Balkom
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Effects of early albuterol (salbutamol) administration on the development of posttraumatic stress symptoms.

Authors:  Ihori Kobayashi; Eve Sledjeski; William Fallon; Eileen Spoonster; David Riccio; Douglas Delahanty
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

Review 3.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

4.  Effects of centrally acting beta adrenergic agonists on discrete trial conditioned avoidance behavior in rats.

Authors:  J F McElroy; J J Stimmel; J M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Bambuterol and terbutaline in human cerebrospinal fluid and plasma.

Authors:  B Rosberg; C Schröder; L Nyberg; J Rosenborg; J E Wirén
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Differential sensitivity to the effects of albuterol on locomotor activity and operant behavior.

Authors:  J M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Adverse reactions to beta 2-agonist bronchodilators.

Authors:  K M Lulich; R G Goldie; G Ryan; J W Paterson
Journal:  Med Toxicol       Date:  1986 Jul-Aug

Review 8.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 9.  Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics.

Authors:  Alida Benfante; Marco Basile; Salvatore Battaglia; Mario Spatafora; Nicola Scichilone
Journal:  Ther Clin Risk Manag       Date:  2016-10-14       Impact factor: 2.423

10.  Spatial Distribution of (R)-salbutamol in Rat Brain Following Nasal and Intravenous Administration Using DESI-MS.

Authors:  Rui Zhang; Jie Wu; Siyu Liu; LiangJun Deng; Junhua Hu; Xi Chen; Wen Tan
Journal:  Pharmaceutics       Date:  2020-01-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.